Daily Single Shot Adductor Canal Block Versus Continuous Adductor Canal Block After Total Knee Arthroplasty
Analgesic Efficacy of Daily Single Shot Adductor Canal Block Versus Continuous Adductor Canal Block After Total Knee Arthroplasty
1 other identifier
interventional
80
1 country
1
Brief Summary
This study will compare the analgesic efficacy of daily single-shot adductor canal block(ABC) versus continuous ACB after total knee arthroplasty (TKA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable postoperative-pain
Started Feb 2023
Typical duration for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2023
CompletedFirst Posted
Study publicly available on registry
February 14, 2023
CompletedStudy Start
First participant enrolled
February 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 8, 2024
CompletedApril 12, 2024
April 1, 2024
8 months
January 25, 2023
April 11, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Average NRS pain score at rest
average of numerical rating scale (0: no pain, 10: worst imaginable pain) pain scores from 8 time points during 48h (+4h, +8h, +12h from end of surgery, 6AM, 2PM, 10PM of postoperative day 1, and 6AM and 2PM of postoperative day 2)
first 48h after end of surgery
Secondary Outcomes (24)
numerical rating scale (0: no pain, 10: worst imaginable pain) pain score at rest at +4h from end of surgery
+4h from end of surgery
numerical rating scale (0: no pain, 10: worst imaginable pain) pain score during movement at +4h from end of surgery
+4h from end of surgery
NRS pain score at rest at +8h from end of surgery
+8h from end of surgery
numerical rating scale (0: no pain, 10: worst imaginable pain) pain score during movement at +8h from end of surgery
+8h from end of surgery
numerical rating scale (0: no pain, 10: worst imaginable pain) pain score at rest at +12h from end of surgery
+12h from end of surgery
- +19 more secondary outcomes
Study Arms (2)
Single shot adductor canal block
EXPERIMENTALContinuous adductor canal block
ACTIVE COMPARATORInterventions
Single shot adductor canal block on the the first and second postoperative day.
A catheter will be placed in the adductor canal and connected to a continuous patient-controlled analgesia pump.
Eligibility Criteria
You may qualify if:
- ASA classification I, II, III
- Patients scheduled for unilateral knee arthroplasty
You may not qualify if:
- Anesthesia other than spinal anesthesia
- Chronic opioid use
- Uncontrolled diabetes of HbA1c\>7.5
- Neuromuscular pathology of the ipsilateral leg
- Second-look knee arthroplasty
- Inability to communicate (e.g. dementia)
- Hypersensitivity to ropivacaine
- BMI \> 40
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seoul National University Hospitallead
- Seoul National Universitycollaborator
Study Sites (1)
Seoul National University Hospital
Seoul, 03080, South Korea
Related Publications (1)
Kim H, Yoo S, Kwon S, Kim Y, Bae J, Kim YJ, Cho YJ, Kim JT, Lim YJ. Analgesic Efficacy of Repeated Daily Injections Versus Continuous Adductor Canal Block After Total Knee Arthroplasty: An Open-Label, Randomized Clinical Trial. Anesth Analg. 2026 Jan 1;142(1):132-139. doi: 10.1213/ANE.0000000000007427. Epub 2025 Feb 18.
PMID: 39964911DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seokha Yoo, MD
Seoul National University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical assistant professor
Study Record Dates
First Submitted
January 25, 2023
First Posted
February 14, 2023
Study Start
February 21, 2023
Primary Completion
October 27, 2023
Study Completion
March 8, 2024
Last Updated
April 12, 2024
Record last verified: 2024-04